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Abstract
Background: Helicobacter pylori infection is one of the most common infections worldwide and is associated with
gastric cancer and peptic ulcer. Bacterial virulence factors such as CagA have been shown to increase the risk of
both diseases. Studies have suggested a causal role for CagA EPIYA polymorphisms in gastric carcinogenesis, and it
has been shown to be geographically diverse. We studied associations between H. pylori CagA EPIYA patterns and
gastric cancer and duodenal ulcer, in an ethnically admixed Western population from Brazil. CagA EPIYA was
determined by PCR and confirmed by sequencing. A total of 436 patients were included, being 188 with gastric
cancer, 112 with duodenal ulcer and 136 with gastritis.
Results: The number of EPIYA C segments was significantly associated with the increased risk of gastric carcinoma
(OR = 3.08, 95% CI = 1.74 to 5.45, p < 10-3) even after adjustment for age and gender. Higher number of EPIYA C
segments was also associated with gastric atrophy (p = 0.04) and intestinal metaplasia (p = 0.007). Furthermore,
patients infected by cagA strains possessing more than one EPIYA C segment showed decreased serum levels of
pepsinogen I in comparison with those infected by strains containing one or less EPIYA C repeat. Otherwise, the
number of EPIYA C segments did not associate with duodenal ulcer.
Conclusions: Our results demonstrate that infection with H. pylori strains harbouring more than one CagA EPIYA C
motif was clearly associated with gastric cancer, but not with duodenal ulcer.
Higher number of EPIYA C segments was also associated with gastric precancerous lesions as demonstrated by
histological gastric atrophic and metaplastic changes and decreased serum levels of pepsinogen I.
Background
Helicobacter pylori colonizes the stomach of more than
half of the world’s population and is associated with
development of complications such as peptic ulcer dis-
ease, gastric cancer, and gastric mucosa-associated lym-
phoid tissue lymphoma [1-4]. The factors that lead few
individuals to develop the associated diseases, while the
majority of infected people remain asymptomatic, are
unknown, but they have been subject of intense
research. Among the host factors, cytokine gene poly-
morphisms were shown to increase the risk of gastric
cancer, specifically IL1B-31, IL1RN, and TNFA-307 sin-
gle nucleotide polymorphisms in European populations,
and IL1RN in a Brazilian population [5-9]. Pathogen
strain-specific factors have been strongly investigated.
Among them, the CagA protein is accepted as a risk fac-
tor for both peptic ulcer disease and gastric cancer
[5,10-12]. In a study of our group, infection by H. pylori
cagA-positive strains had an odds ratio (OR) of 11.9 for
gastric cancer, after adjusting for host polymorphisms
and other variables, whereas the strongest host factor
was IL1RN 2 allele, with an OR of 1.9 [5].
cagA belongs to a cag PAI (pathogenicity island) that
codes a type IV secretion system (T4SS) associated with
increased secretion of IL-8, a very strong proinflamma-
tory chemokine that participates in the gastritis induced
by H. pylori infection. The T4SS is also responsible for
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the entrance of CagA protein into the gastric epithelial
cells where CagA is phosphorylated on the tyrosine resi-
due within the phosphorylation motifs in the carboxi-
terminal variable region of the protein. These motifs are
defined as EPIYA (Glu-Pro-Ile-Tyr-Ala) A, B, C and D
according to different flanking aminoacids. CagA protein
nearly always possesses EPIYA A and B segments that
are followed by none, one, two or three C segments, in
strains circulating in the Western countries, or a D seg-
ment, in East Asian countries. The EPIYA C and D are
the main sites for phosphorylation of CagA. Phosphory-
lated CagA forms a physical complex with SHP-2 phos-
phatase and triggers abnormal cellular signals leading to
deregulation of cell growth, cell to cell contact and cell
migration, elongation of epithelial cells and increase of
epithelial cell turnover, which enhance the risk of
damaged cells to acquire precancerous genetic changes.
Carrying the type D EPIYA or multiple C repeats is
associated with increased SHP-2 phosphatase activity
induced by CagA [13,14], which raises the possibility
that infection by CagA strains possessing higher number
EPIYA C segments predisposes to precancerous lesions
and gastric cancer.
In fact, this hypothesis has been tested in Eastern
countries, but the study results are discordant. Azuma
et al. [15] found increased proportion of EPIYA D
strains among patients with atrophic gastritis and gastric
cancer, but other authors have been unable to reproduce
these results [16,17]. Similarly, in Western populations,
significant association between gastric cancer and
increased number of EPIYA C motifs could be demon-
strated in two studies [18,19], maybe either by the small
number of included patients in the other studies
[20-22], or by regional/ethnics differences as already
demonstrated for other H. pylori virulence markers
[23,24]. Furthermore, discrepancies have been also
demonstrated in studies evaluating the number of
EPIYA C motifs and duodenal ulcer [19,25], which
deserves in deep investigations because duodenal ulcer
and gastric cancer are mutually exclusive H. pylori-asso-
ciated diseases.
Therefore we evaluated whether increased number of
CagA EPIYA C phosphorylation motifs is associated
with gastric cancer and/or duodenal ulcer including a
large series of patients to avoid bias and to allow adjust-
ment for age and gender in a Western population from
Brazil. Since duodenal ulcer and gastric carcinoma are
mutually exclusive diseases, and cagA is a risk factor for
both conditions, we also evaluated whether the number
of EPIYA C segments of the strains isolated from
patients with duodenal ulcer differed from that of the
strains isolated from gastric cancer patients. Because
gastric atrophic and metaplastic changes - precancerous
lesions - lead to impairment of the production of pepsi-
nogen I (PGI) by chief and mucous neck cells in the
corpus and fundic glands, we evaluated whether the
higher number of EPIYA C motifs was associated with
the serum pepsinogen levels.
Results
The characteristics of the patients are shown in the
Table 1. The presence of H. pylori-specific ureA and
16S rRNA was successfully confirmed by PCR in all stu-
died strains and the cagA PCRs were positive, by at
least one of the method used, in all strains.
Determination of the CagA EPIYA pattern
PCR amplified products from all cagA-positive strains
showed distinct patterns in the 3’ variable region of
cagA. An electrophoresis gel representing the different
CagA EPIYA types is shown in the Figure 1. The PCR
results were confirmed by sequencing in seventy five
randomly selected PCR products from patients of each
group.
No EPIYA D was found in the H. pylori strains stu-
died. The distribution of the EPIYA genotypes is shown
in the Table 1.
Association between the numbers of EPIYA C segments
and gastric cancer and duodenal ulcer
Colonization by H. pylori CagA-positive strains posses-
sing two or three EPIYA C motifs was more frequently
observed (p < 10-3) in the gastric cancer (78/188, 41.5%)
than in the gastritis (25/136, 18.4%) patients. The asso-
ciation remained strongly significant even after adjusting
for age and gender by means of logistic regression
Table 1 Patient characteristics and distribution of CagA EPIYA genotypes according to H. pylori-associated diseases
Gastritis 136 (%) Gastric cancer 188 (%) Duodenal ulcer 112 (%)
Mean Age (SD) 52.5 (16.9) 62.3 (13.9) 43.5 (15.1)
Male sex 48 (35.3) 114 (60.6) 53 (47.3)
EPIYA-AB 3 (2.2) 3 (1.6) 4 (3.6)
EPIYA-ABC 108 (79.4) 107 (56.9) 93 (83.0)
EPIYA-ABCC 21 (15.4) 65 (34.6) 15 (13.4)
EPIYA-ABCCC 4 (3.0) 13 (6.9) 0 (0.0)
SD, Standard Deviation.
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(Table 2). The Hosmer-Lemeshow test showed good fit-
ness of the model (Chi-square = 3.98, 8 degrees of free-
dom, p = 0.86, with 10 steps). Otherwise, the number of
EPIYA C segments did not associate with duodenal
ulcer (Table 2).
Because it might be speculated that the number of
EPIYA C motifs increases with increasing age, we also
constructed a model with the number of EPIYA C being
the dependent variable and the age, sex and H. pylori-
associated diseases as independent covariables. Increased
EPIYA C segments did not associate with age (p = 0.13),
sex (p = 0.66) and duodenal ulcer (p = 0.29) but
remained associated with gastric cancer (p < 10-3, OR =
2.81; 95% CI = 1.64 - 4.82).
Association between mixed strain colonization and
diseases
Mixed strain infection was observed in 57 (13.08%)
patients and it was significantly more frequent in
patients with gastric cancer (38/188, 20.2%) than in
those with gastritis (14/136, 10.3%) with an OR for gas-
tric carcinoma of 2.21 (95%CI = 1.10 to 4.50). Other-
wise, mixed infection was less frequently observed in
duodenal ulcer patients (5/112, 4.5%) with a trend to a
negative association (p = 0.09).
Association between the numbers of EPIYA C segments
and serum PGI levels
The pepsinogen I serum levels were significantly higher
(p = 0.01) in duodenal ulcer (mean 161.67 ± 102.36 μg/
L) than in gastritis (100.37 ± 70.85 μg/L).
The patients infected by CagA strains possessing two
or three EPIYA C segments showed decreased levels of
PGI when compared with those with infection by CagA
strains possessing ≤ 1 EPIYA C segment (duodenal
ulcer: 179.67 ± 83.30 vs. 67.01 ± 34.30, respectively, p =
0.02 and gastritis: 109.26 ± 85.61 vs. 57.55 ± 34.61,
respectively, p = 0.01).
Association between the numbers of EPIYA C repeats and
gastric histological alterations and tumour classification
Increased number of EPIYA C segments was associated
with the presence of precancerous lesions, either atrophy
(p = 0.04) or intestinal metaplasia (p = 0.007), but not
with the other histological parameters. Also, the infection
by strains carrying increased EPIYA C motifs did not
associate with intestinal or diffuse tumour type (p = 0.34).
Discussion
In this study, by evaluating a large series of patient, we
demonstrated that those infected by CagA-positive H.
pylori strains possessing more than one EPIYA C motif
are at thrice-fold increased risk for developing gastric
cancer. The strengths of our study include adequate
sample size, identification of strains by means of PCR
with confirmation by sequencing and adjustment for
confounding factors by logistic regression analysis.
CagA is considered to be an important bacterial viru-
lence factor associated with both gastric adenocarcinoma
and duodenal ulcer disease [2,5,11,12,26]. The number
Figure 1 Electrophoresis of representative samples with each
of the CagA EPIYA types seen in patients with H. pylori-
associated diseases. Column 1: 100 bp standard; Column 2: EPIYA-
AB; Columns 3, 8, 11, and 12: EPIYA-ABC; Column 4: EPIYA-ABC +
-ABCCC; Columns 5 and 13: EPIYA-ABCC; Column 6: EPIYA ABCCC;
Column 7: EPIYA-ABCC + -ABCCC; Column 9: EPIYA-ABC + -ABCC +
-ABCCC; Column 10: EPIYA-ABC + -ABCC.
Table 2 Association between number of CagA EPIYA C motifs and H. pylori-associated diseases
Univariate analysis Multivariate analysis
p OR 95% CI p
Gastric cancer
- Increasing age < 10-3 1.04 1.03 - 1.06 < 10-3
- Female sex < 10-3 0.29 0.18 - 0.48 < 10-3
- High-risk EPIYA (ABCC or ABCCC) < 10-3 3.08 1.74 - 5.45 < 10-3
Duodenal ulcer
- Increasing age < 10-3 1.03 1.02 - 1.05 < 10-3
- Female sex 0.04 1.26 0.73 - 2.18 0.41
- High-risk EPIYA (ABCC or ABCCC) 0.29 - - -
The Hosmer-Lemeshow test showed good fitness of the model of gastric cancer (8 degrees of freedom, p = 0.86, with 10 steps) and duodenal ulcer (8 degrees
of freedom, p = 0.25, with 10 steps).
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and pattern of phosphorylation motifs seem to further
stratify the risk associated with individual strains [18,27].
It has been demonstrated that H. pylori CagA EPIYA
patterns have a significant geographic variability and
closely follow patterns of historical human migrations.
EPIYA D is a characteristic Asian EPIYA pattern that
virtually does not occur in the Western H. pylori strains
[28]. The Brazilians form an unique Western population
because, despite the multiple origins and the consequent
wide diversity of phenotypic appearance, there has been
a substantial degree of inter-ethnic breeding and thus
most individuals cannot be ascribed to any of the found-
ing groups on the basis of genetic background, rather
they carry about 33% of genes from each of the major
races that historically composed the country (Cauca-
sians, Africans and Amerindians) [29]. With this back-
ground, it would be expected to find some CagA EPIYA
D in our H. pylori strains, as it has been detected
among Amerindians (in keeping with the theory that
initially people from Asia populated the Americas
migrating from the East Asia), but we did not detect
any EPIYA D in our population.
Unfortunately, there are few studies in respect to the
association between EPIYA C number and H. pylori
associated diseases in Western populations with discor-
dant results among them. Basso et al. [19] showed that
higher number of EPIYA C segments was associated
with gastric carcinoma in a Caucasian population from
Italy, similarly to the results of Yamaoka et al. [18] eval-
uating American patients from Texas. Otherwise, no
association was observed when Colombian patients were
evaluated in the Yamaoka’s study [18] in accordance
with the results obtained by Acosta et al. [22], whereas
Sicinschi et al. [21] observed associations between
increased EPIYA C segments and precancerous lesions.
Also, non-conclusive results published by Argent et al.
[20] evaluating 44 strains from African patients the
authors showed tendency of association between CagA
with two or more EPIYA C segments and gastric cancer.
These differences may be explained by different study
designs, sample size, populations and geographical diver-
sity of H. pylori markers of pathogenicity, in respect to
the CagA EPIYA pattern, highlighting the need of study-
ing different geographical regions.
The results of this study showed that higher number
of EPIYA C segments is associated with gastric cancer
and with pre-malignant lesions, atrophy and intestinal
metaplasia of the corpus mucosa in the group of
patients with gastritis. In agreement with these find-
ings, we also demonstrated that serum concentration
of PGI was twice decreased in the patients infected by
cagA-positive strains with two or three EPIYA C
motifs. Because PGI is secreted by chief cells and
mucous neck cells in the corpus and fundic glands,
serum PGI levels reflect the functional and morpholo-
gic status of the oxyntic gastric mucosa; thus, gastric
atrophic/metaplastic changes lead to decreased PGI
serum levels [30,31]. Although the corpus mucosa of
patients with H. pylori associated duodenal ulcer is
either mildly or not inflamed, the PGI serum levels
were also decreased in duodenal ulcer patients infected
by strains containing higher number of EPIYA C
segments.
The results of the present study strengthen the poten-
tial role of CagA polymorphism in the development of
gastric cancer in agreement with the results of the pre-
vious studies [18,19]. However, we can not exclude the
possibility that the genetic constitution of the host,
more than the bacterium strain, might predispose to
atrophic gastritis and the H. pylori strains carrying
increasing numbers of EPIYA C repeats would have an
advantage over other strains in colonizing the new gas-
tric environment or alternatively a more complex inter-
play of both mechanisms.
In respect to duodenal ulcer, also the results of the
studies are discordant [19,25]. Our results are in agree-
ment with those reported by Basso et al. [19] who also
did not find association between the disease and the
number of EPIYA C segments in an Italian population.
Notably, none patient with duodenal ulcer of our cohort
was colonized by CagA possessing three EPIYA C seg-
ments. As suggested by Yamaoka et al. [18], it is possi-
ble that strains with higher number of EPIYA C
segments may be less resistant to the acid [18].
We also evaluated whether colonization by different
strains (mixed infection) could be associated with dis-
ease outcomes. We found that gastric cancer patients
were significantly more often colonized by mixed
strains, whereas patients with duodenal ulcer had a
trend toward less mixed strain colonization. One possi-
bility is that patients with gastric cancer would have
areas of gastric mucosa showing cancer transformation,
alternating with areas of atrophy, intestinal metaplasia,
dysplasia, and normal mucosa, each of them represent-
ing microenvironments that would be selectively advan-
tageous to mixed infections [32,33].
Conclusions
In conclusion, we found that infection by H. pylori
CagA-positive strains harbouring multiple EPIYA C
repeats is associated with gastric precancerous lesions
and gastric cancer, but not with duodenal ulcer in an
ethnically diverse, admixed, Western population.
Although infection by H. pylori cagA-positive strains is
a risk factor for the mutually exclusive diseases, gastric
cancer and duodenal ulcer, CagA strains possessing
higher number of EPIYA C segments were associated
with gastric cancer, but not with duodenal ulcer.
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Higher number of EPIYA C segments was also asso-
ciated with gastric precancerous lesions as demonstrated
by histological gastric atrophic and metaplastic changes
and decreased serum levels of pepsinogen I.
Methods
Patients
We included 436 patients infected with cagA-positive
strains of H. pylori (188 with gastric cancer, 112 with
duodenal ulcer and 136 with gastritis), among those
who were submitted to endoscopy to clarify the origin
of symptoms related to the upper gastrointestinal
tract or who underwent gastric surgery to remove
gastric carcinoma at the University Hospital/UFMG,
Luxemburgo, and Mário Penna Hospitals, in Belo
Horizonte, Brazil. Most of the included individuals
(>80%) were of low socioeconomic level with similar
cultural habits, and all were native of Minas Gerais
state with the same ethnic background, approximately
33% of Portuguese, 33% of Amerindian and 33% of
African ancestry, homogeneously present in each sub-
ject [29].
The study was approved by the institutional Ethics
Committees and informed consent was obtained from
all patients. The transport, culture, and microbiological
identification of the bacterial isolates were performed as
previously described [34,35].
Histology
In the group of gastritis and duodenal ulcer patients,
endoscopic biopsy samples of the antral and oxyntic
gastric mucosa were obtained for histological and
microbiological study. Antral and oxyntic biopsy speci-
mens were fixed in 10% formalin and embedded in par-
affin wax, and 4-μm-thick histological sections were
stained with carbolfuchsin for H. pylori investigation
[35] and hematoxycilin and eosin for histological evalua-
tion according to the updated Sydney System [36]. In
the group of gastric cancer patients, the fragments were
obtained from the stomach removed by gastrectomy
after opening it along the greater curvature within one
hour of resection. The tumour was classified according
to Lauren [37].
Extraction of bacterial DNA
Bacterium DNA obtained from 60 mm Petri dish
growth was extracted using the QIAmp (QIAGEN, Hil-
den, Germany) kit according to manufacturer’s recom-
mendations with minor modifications. Distilled water
was used as a reaction control. The DNA concentration
was determined by spectrophotometry using NanoDrop
2000 (Thermo Scientific, Wilmington, NC) and stored
at -20°C until use.
Amplification of H. pylori-specific ureA and 16S rRNA
genes
The presence of specific ureA and 16S rRNA genes was
evaluated according to Clayton et al. [38] and Fox et al.
[39] respectively. The standard Tx30a H. pylori strain
was used as a positive control, and an Escherichia coli
strain and distilled water were both used as negative
controls.
The thermocycler GeneAmp PCR System 9700
(Applied Biosystems, Foster City, CA) was used for all
reactions. The amplified products were electrophoresed
in 2% agarose gel, stained with ethidium bromide, and
analyzed in an ultraviolet light transilluminator.
Amplification of the cagA gene
The cagA gene was amplified by means of two pre-
viously described primer pairs [40,41]. A H. pylori strain
from our collection (1010-95), known to be cagA-posi-
tive, was used as a positive control, and Tx30a H. pylori
strain lacking cagA and distilled water were both used
as negative controls. The H. pylori strains were consid-
ered to be cagA-positive when at least one of the two
reactions was positive.
Amplification of the 3’ variable region of cagA
For the PCR amplification of the 3’ variable region of
the cagA gene (that contains the EPIYA sequences), 20
to 100 ng of DNA were added to 1% Taq DNA poly-
merase buffer solution (KCl 50 mM and Tris-HCl 10
mM), 1.5 mM MgCl2, 100 μM of each deoxynucleotide,
1.0 U Platinum Taq DNA polymerase (Invitrogen, São
Paulo, Brazil), and 10 pmol of each primer, for a total
solution volume of 20 μL. The primers used were pre-
viously described by Yamaoka et al. [27]. The reaction
conditions were: 95°C for 5 minutes, followed by 35
cycles of 95°C for 1 minute, 50°C for 1 minute, and 72°
C for 1 minute, ending with 72°C for 7 minutes. The
amplified products were electrophoresed in 1.5% agarose
gel that was stained with ethidium bromide, and ana-
lyzed in an ultraviolet light transilluminator. The reac-
tion yielded products of 500 to 850 bp according to the
number of EPIYA C. This methodology also allows the
detection of mixed infection.
Sequencing of the 3’ variable region of cagA
A significant subset of samples (around 75 patients of
each group) was randomly selected for sequencing, in
order to confirm the PCR results. PCR products were
purified with the Wizard SV Gel and PCR Clean-Up
System (Promega, Madison, MI) according to the manu-
facturer’s recommendations. Purified products were
sequenced using a BigDye® Terminator v3.1 Cycle
Sequencing Kit in an ABI 3130 Genetic Analyzer
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(Applied Biosystems, Foster City, CA). The sequences
obtained were aligned using the CAP3 Sequence Assem-
bly Program (available from: http://pbil.univ-lyon1.fr/
cap3.php). After alignment, nucleotide sequences were
transformed into aminoacid sequences using the Blastx
program (available from: http://blast.ncbi.nlm.nih.gov/
Blast.cgi) and compared to sequences deposited into the
GenBank (http://www.ncbi.nlm.nih.gov/Genbank/).
Determination of the serum PGI levels
The serum concentrations of PGI were determined in
the patients with gastritis and duodenal ulcer by a speci-
fic ELISA (Biohit, Helsinki, Finland) according to manu-
facturer’s recommendations.
Statistical analysis
A sample size of at least 112 subjects in each group, in
order to show a 15% difference among groups with a
power of 80%, alpha of 5%, and confidence interval of
95% was calculated with the Epi Info program version
3.5.1 (Centres for Disease Control and Prevention,
Atlanta, GA).
Association between the number of EPIYA C motifs
and gastric cancer was initially evaluated in univariate
analysis, and variables with a p-value less than 0.2 were
included in the final model of logistic regression, con-
trolling for the influences of age and sex. We also evalu-
ated the effect of the gender and age in the number of
EPIYA C segments in a model with the number of
EPIYA C being the dependent variable and the age, sex
and H. pylori-associated diseases as independent covari-
ables. The logistic model fitness was evaluated with the
Hosmer-Lemeshow test. Because the PGI levels were
not normally distributed the data log transformed and
became normal. Associations were, thus, evaluated by
Student’s t test (mean ± standard deviation). Association
among the number of EPIYA C segments and the
degree of gastric inflammation, atrophy and intestinal
metaplasia was done by the two-tailed Mann-Whitney
Test. The level of significance was set at a p value ≤
0.05.
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